This Week’s CGT News: Bristol Myers Ends Cellares Manufacturing Agreement - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

This Week’s CGT News: Bristol Myers Ends Cellares Manufacturing Agreement

A first-in-human study reduces stem-cell collection and manufacturing times, Bristol Myers ends its Breyanzi agreement with Cellares, and two approaches strengthen CAR T-cell activity against solid tumors

  • August 31, 2026

  • 5 min

Share

Original Source(s)

This Week’s CGT News: Bristol Myers Ends Cellares Manufacturing Agreement

  • August 31, 2026

Related Content

Trastuzumab deruxtecan treatment for HER2-low metastatic scrotal extramammary Paget’s disease with bone marrow involvement: a case report

New Podcast Feature: Dr. Geoffrey Young on SurgOnc Today

Join Baptist Health's Dr. Geoffrey Young as he joins Drs. Sonia Cohen and Ashley Holder on the latest episode of SurgOnc Today.

  • by

  • August 28, 2026

  • 1 min
Cancer Communication in an Era of Fragmented Trust